Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Mar;111(3):681–686. doi: 10.1111/j.1476-5381.1994.tb14791.x

Interleukin-1 beta enhances capsaicin-induced neurogenic vasodilatation in the rat skin.

M K Herbert 1, P Holzer 1
PMCID: PMC1910067  PMID: 8019746

Abstract

1. This study examined the effect of interleukin-1 beta (IL-1 beta) on the capsaicin-induced increase in cutaneous blood flow of anaesthetized rats as measured by laser Doppler flowmetry. 2. The substances were administered by intraplantar subcutaneous injection of 10 microliters-volumes, saline being injected into one hindpaw and IL-1 beta into the other. 3. IL-1 beta (0.5-500 pg) was without effect on blood flow on its own but dose-dependently enhanced the hyperaemic response to intraplantar capsaicin (0.3 microgram) up to 180% (P < 0.05) of the response seen in saline-treated paws. 4. Il-1 beta-(163-171), a fragment devoid of proinflammatory activity, failed to enhance capsaicin-induced hyperaemia when given at a dose of 50 pg. 5. Indomethacin (10 mg kg-1, i.p.) did not alter the capsaicin-induced vasodilatation but prevented IL-1 beta (50 pg) from augmenting the hyperaemic response to capsaicin. 6. The hyperaemia evoked by intraplantar calcitonin gene-related peptide (0.038-3.8 ng) was not altered by IL-1 beta (50 pg). 7. These data indicate that IL-1 beta enhances the cutaneous hyperaemic response to afferent nerve stimulation with capsaicin in a prostaglandin-dependent manner. This proinflammatory action of the cytokine appears to arise from sensitization of afferent nerve endings.

Full text

PDF
681

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoni G., Presentini R., Perin F., Tagliabue A., Ghiara P., Censini S., Volpini G., Villa L., Boraschi D. A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol. 1986 Nov 15;137(10):3201–3204. [PubMed] [Google Scholar]
  2. Barnes P. J. Neurogenic inflammation in airways. Int Arch Allergy Appl Immunol. 1991;94(1-4):303–309. doi: 10.1159/000235392. [DOI] [PubMed] [Google Scholar]
  3. Basbaum A. I., Levine J. D. The contribution of the nervous system to inflammation and inflammatory disease. Can J Physiol Pharmacol. 1991 May;69(5):647–651. doi: 10.1139/y91-096. [DOI] [PubMed] [Google Scholar]
  4. Chandrasekhar S., Harvey A. K., Hrubey P. S., Bendele A. M. Arthritis induced by interleukin-1 is dependent on the site and frequency of intraarticular injection. Clin Immunol Immunopathol. 1990 Jun;55(3):382–400. doi: 10.1016/0090-1229(90)90126-b. [DOI] [PubMed] [Google Scholar]
  5. Dinarello C. A. Interleukin-1 and interleukin-1 antagonism. Blood. 1991 Apr 15;77(8):1627–1652. [PubMed] [Google Scholar]
  6. Dinarello C. A. Role of interleukin-1 in infectious diseases. Immunol Rev. 1992 Jun;127:119–146. doi: 10.1111/j.1600-065x.1992.tb01411.x. [DOI] [PubMed] [Google Scholar]
  7. Ferreira S. H., Lorenzetti B. B., Bristow A. F., Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature. 1988 Aug 25;334(6184):698–700. doi: 10.1038/334698a0. [DOI] [PubMed] [Google Scholar]
  8. Follenfant R. L., Nakamura-Craig M., Henderson B., Higgs G. A. Inhibition by neuropeptides of interleukin-1 beta-induced, prostaglandin-independent hyperalgesia. Br J Pharmacol. 1989 Sep;98(1):41–43. doi: 10.1111/j.1476-5381.1989.tb16860.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience. 1988 Mar;24(3):739–768. doi: 10.1016/0306-4522(88)90064-4. [DOI] [PubMed] [Google Scholar]
  10. Holzer P. Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol. 1992;121:49–146. doi: 10.1007/BFb0033194. [DOI] [PubMed] [Google Scholar]
  11. Hom J. T., Cole H., Estridge T., Gliszczynski V. L. Interleukin-1 enhances the development of type II collagen-induced arthritis only in susceptible and not in resistant mice. Clin Immunol Immunopathol. 1992 Jan;62(1 Pt 1):56–65. doi: 10.1016/0090-1229(92)90022-g. [DOI] [PubMed] [Google Scholar]
  12. Howells G. L., Chantry D., Feldmann M. Interleukin 1 (IL-1) and tumour necrosis factor synergise in the induction of IL-1 synthesis by human vascular endothelial cells. Immunol Lett. 1988 Oct;19(2):169–173. doi: 10.1016/0165-2478(88)90138-1. [DOI] [PubMed] [Google Scholar]
  13. Hughes S. R., Brain S. D. A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin. Br J Pharmacol. 1991 Nov;104(3):738–742. doi: 10.1111/j.1476-5381.1991.tb12497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Libby P., Ordovas J. M., Auger K. R., Robbins A. H., Birinyi L. K., Dinarello C. A. Endotoxin and tumor necrosis factor induce interleukin-1 gene expression in adult human vascular endothelial cells. Am J Pathol. 1986 Aug;124(2):179–185. [PMC free article] [PubMed] [Google Scholar]
  15. Lippe I. T., Holzer P. Participation of endothelium-derived nitric oxide but not prostacyclin in the gastric mucosal hyperaemia due to acid back-diffusion. Br J Pharmacol. 1992 Mar;105(3):708–714. doi: 10.1111/j.1476-5381.1992.tb09043.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Lowenthal J. W., Cerottini J. C., MacDonald H. R. Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. J Immunol. 1986 Aug 15;137(4):1226–1231. [PubMed] [Google Scholar]
  17. Lynn B., Ye W., Cotsell B. The actions of capsaicin applied topically to the skin of the rat on C-fibre afferents, antidromic vasodilatation and substance P levels. Br J Pharmacol. 1992 Oct;107(2):400–406. doi: 10.1111/j.1476-5381.1992.tb12758.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Maggi C. A., Meli A. The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen Pharmacol. 1988;19(1):1–43. doi: 10.1016/0306-3623(88)90002-x. [DOI] [PubMed] [Google Scholar]
  19. McGillis J. P., Mitsuhashi M., Payan D. G. Immunomodulation by tachykinin neuropeptides. Ann N Y Acad Sci. 1990;594:85–94. doi: 10.1111/j.1749-6632.1990.tb40470.x. [DOI] [PubMed] [Google Scholar]
  20. Mochan E., Uhl J., Newton R. Evidence that interleukin-1 induction of synovial cell plasminogen activator is mediated via prostaglandin E2 and cAMP. Arthritis Rheum. 1986 Sep;29(9):1078–1084. doi: 10.1002/art.1780290904. [DOI] [PubMed] [Google Scholar]
  21. Moskowitz M. A., Buzzi M. G. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol. 1991;238 (Suppl 1):S18–S22. doi: 10.1007/BF01642901. [DOI] [PubMed] [Google Scholar]
  22. O'Byrne E. M., Blancuzzi V. J., Wilson D. E., Wong M., Peppard J., Simke J. P., Jeng A. Y. Increased intra-articular substance P and prostaglandin E2 following injection of interleukin-1 in rabbits. Int J Tissue React. 1990;12(1):11–14. [PubMed] [Google Scholar]
  23. O'Byrne E. M., Blancuzzi V., Wilson D. E., Wong M., Jeng A. Y. Elevated substance P and accelerated cartilage degradation in rabbit knees injected with interleukin-1 and tumor necrosis factor. Arthritis Rheum. 1990 Jul;33(7):1023–1028. doi: 10.1002/art.1780330715. [DOI] [PubMed] [Google Scholar]
  24. O'Byrne E. M., Blancuzzi V., Wilson D., Wong M., Peppard J., Simke J. P., Jeng A. Y. Effects of indomethacin, triamcinolone, and dexamethasone on recombinant human interleukin-1-induced substance P and prostaglandin E2 levels in rabbit knee joints. Agents Actions. 1991 Sep;34(1-2):46–48. doi: 10.1007/BF01993234. [DOI] [PubMed] [Google Scholar]
  25. Oberg P. A., Tenland T., Nilsson G. E. Laser-Doppler flowmetry--a non-invasive and continuous method for blood flow evaluation in microvascular studies. Acta Med Scand Suppl. 1984;687:17–24. doi: 10.1111/j.0954-6820.1984.tb08735.x. [DOI] [PubMed] [Google Scholar]
  26. Pettipher E. R., Higgs G. A., Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci U S A. 1986 Nov;83(22):8749–8753. doi: 10.1073/pnas.83.22.8749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schweizer A., Feige U., Fontana A., Müller K., Dinarello C. A. Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels. Agents Actions. 1988 Dec;25(3-4):246–251. doi: 10.1007/BF01965025. [DOI] [PubMed] [Google Scholar]
  28. Sharkey K. A. Substance P and calcitonin gene-related peptide (CGRP) in gastrointestinal inflammation. Ann N Y Acad Sci. 1992;664:425–442. doi: 10.1111/j.1749-6632.1992.tb39781.x. [DOI] [PubMed] [Google Scholar]
  29. Stimpson S. A., Dalldorf F. G., Otterness I. G., Schwab J. H. Exacerbation of arthritis by IL-1 in rat joints previously injured by peptidoglycan-polysaccharide. J Immunol. 1988 May 1;140(9):2964–2969. [PubMed] [Google Scholar]
  30. van de Loo A. A., Arntz O. J., van den Berg W. B. Flare-up of experimental arthritis in mice with murine recombinant IL-1. Clin Exp Immunol. 1992 Feb;87(2):196–202. doi: 10.1111/j.1365-2249.1992.tb02974.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES